Combined MYC and P53 Defects Emerge at Medulloblastoma Relapse and Define Rapidly Progressive, Therapeutically Targetable Disease

Rebecca Hill, Sanne Kuijper, Janet Lindsey, Kevin Petrie, Ed Schwalbe, Karen Barker, Jessica Boult, Daniel Williamson, Zai Ahmad, Albert Hallsworth, Sarra Ryan, Evon Poon, Simon Robinson, Ruth Ruddle, Florence Raynaud, Louise Howell, Colin Kwok, Abhijit Joshi, Sarah Leigh Nicholson, Stephen CrosierDavid Ellison, Stephen Wharton, Keith Robson, Antony Michalski, Darren Hargrave, Thomas Jacques, Barry Pizer, Simon Bailey, Fredrik J. Swartling, William Weiss, Louis Chesler, Steven Clifford*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

134 Citations (Scopus)
2 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Combined MYC and P53 Defects Emerge at Medulloblastoma Relapse and Define Rapidly Progressive, Therapeutically Targetable Disease'. Together they form a unique fingerprint.

Medicine & Life Sciences